Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01587144
What this trial is testing

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Who this might be right for
Glioblastoma Multiforme
Spectrum Pharmaceuticals, Inc 18
Early research (Phase 1)Study completedNCT02502708
What this trial is testing

Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliomaGliosarcoma+5 more
NewLink Genetics Corporation 81
Testing effectiveness (Phase 2)Study completedNCT00616005
What this trial is testing

Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide

Who this might be right for
Glioblastoma
Duke University 41
Not applicableLooking for participantsNCT06989086
What this trial is testing

FearLess in NeuroOncology

Who this might be right for
Primary Malignant Brain TumorGlioblastoma (GBM)Astrocytoma+2 more
Virginia Commonwealth University 112
Early research (Phase 1)Study completedNCT00100880
What this trial is testing

Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+23 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00961090
What this trial is testing

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

Who this might be right for
Glioblastoma
Matthew R Quigley 72
Not applicableStudy completedNCT03630861
What this trial is testing

Establishment of a Signature of Circulating microRNA as a Tool to Aid Diagnosis of Primary Brain Tumors in Adults

Who this might be right for
Brain Tumors
Assistance Publique - Hôpitaux de Paris 160
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Testing effectiveness (Phase 2)Study completedNCT01301430
What this trial is testing

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

Who this might be right for
Glioblastoma Multiforme
Oryx GmbH & Co. KG 18
Not applicableEnded earlyNCT02967380
What this trial is testing

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Who this might be right for
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+22 more
University of Southern California 14
Testing effectiveness (Phase 2)Study completedNCT02038218
What this trial is testing

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

Who this might be right for
Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
DEKK-TEC, Inc. 29
Early research (Phase 1)Not Yet RecruitingNCT06524063
What this trial is testing

Targeted Survivin DC Cell Injection for the Treatment of GBM

Who this might be right for
Glioblastoma
Beijing Tricision Biotherapeutics Inc 9
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT01032200
What this trial is testing

Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

Who this might be right for
Brain TumorsNervous System TumorsCognition Disorders+1 more
Wake Forest University Health Sciences 54
Early research (Phase 1)Study completedNCT01076530
What this trial is testing

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+31 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT01465347
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBMGlioma
Diffusion Pharmaceuticals Inc 59
Testing effectiveness (Phase 2)Ended earlyNCT02711137
What this trial is testing

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 137
Early research (Phase 1)Study completedNCT00027625
What this trial is testing

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT04790097
What this trial is testing

FET-PET Directed Simultaneous In-field Boost for Primary GBM

Who this might be right for
Glioblastoma Multiforme
Prof. Franciszek Lukaszczyk Memorial Oncology Center 17
Next Page